Back to School for Biotech
How Academia and Industry Can Collaborate to Advance Biologic Drug Development and Manufacturing
The Shifting Field of Stem Cell Regulations
Recent FDA Hearings Addressed Concerns Around Clinics Offering Cellular Therapies to Consumers
Enhancing Graduate and Postdoc Education for a Sustainable Workforce
Ph.D.-Trained Biomedical Scientists Can No Longer Count on Finding Academic Positions Upon Graduation
Unlucky 13: Top Clinical Trial Failures of 2016
In Missing Primary Endpoints, These Drugs Touched Off Stock Selloff, Layoffs, and Worse
- Dolomite Centre
- Unit 1, Anglian Business Park
- Orchard Rd.
- Royston , SG8 5TW
- UNITED KINGDOM
Dolomite has its roots in Syrris, which was founded in 2001 by Mark Gilligan and Richard Gray to address the challenges faced by the pharmaceutical industry. While Syrris focuses on flow chemistry and microreactors, Dolomite was set up as a subsidiary to provide microfluidic solutions to customers around the world in a very wide range of applications outside the field of research chemistry.